Altimmune, Inc.·4

Sep 29, 4:20 PM ET

Durso Jerome Benedict 4

4 · Altimmune, Inc. · Filed Sep 29, 2025

Insider Transaction Report

Form 4
Period: 2025-09-25
Durso Jerome Benedict
DirectorPresident and CEO
Transactions
  • Award

    Stock Options (option to buy)

    2025-09-25+48,80048,800 total
    Exercise: $3.92Exp: 2035-09-25Common Stock, par value $0.0001 (48,800 underlying)
Footnotes (1)
  • [F1]The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 25, 2025, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    tm2527377-8_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT